Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin (1-7) in Moderate to Severe Traumatic Brain Injury (TBI)
NCT06282965Phase 2Recruiting
- Sponsor
- University of Arizona
- Start
- May 2024
- Primary completion
- Sep 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of angiotensin-(1-7) in traumatic brain injury (TBI), sponsored by University of Arizona. Started May 2024; status: recruiting.
02
Drugs
angiotensin-(1-7)
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06282965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06282965.